The president of one of the leading healthcare technology companies in the world spoke recently to physicians and supporters of Miami Cardiac & Vascular Institute  about how new and emerging digital technology will help the way people receive healthcare and address disease.
(The Baptist Health South Florida News Team hears from Philips’ global president Frans van Houten and other leaders about advances in healthcare technology, including those in partnership with Miami Cardiac & Vascular Institute. Video by George Carvalho).
Frans van Houten, president and chief executive officer of Royal Philips, spoke at the 6th installment of the Baptist Health Al & Janie Nahmad Speaker Series: Thought Leaders in Medicine. Highlighting the latest technology innovations in healthcare, Mr. van Houten emphasized the use of data and how sharing it among healthcare teams is critical to equipping caregivers with tools that empower personal health.
“One of the most common themes I hear from healthcare company leaders globally is the need to improve on-target and on-time diagnoses in real time,” Mr. van Houten said. “The need to connect patients and providers in a digital world presents a tremendous opportunity for digital technology in healthcare.”
The lecture was one of several events celebrating the opening of an expanded  Miami Cardiac & Vascular Institute. The Institute has been a test site for Philips’ technology since its inception 30 years ago. Most recently, Philips and Miami Cardiac & Vascular Institute announced the first North American installation of the Azurion Image Guided Therapy (IGT) system, designed to treat people with cardiovascular disease quicker and with less radiation.
Barry T. Katzen, M.D. , founder and chief medical executive of Miami Cardiac & Vascular Institute, said the IGT system and other recent innovations put into place are perfectly aligned with what the Institute is all about – using the best technology to provide patients with the highest quality of care.
By providing physicians and clinicians with the tools to diagnose and treat patients more accurately and faster, Philips is advancing “precision medicine” – the ability to adapt and speed up treatments to deliver personalized care. Working with partners such as Miami Cardiac & Vascular Institute, the company has a goal of improving 3 billion lives per year by 2025.
Miami Cardiac & Vascular Institute serves as an integral innovation partner for Philips by providing valuable clinical insights that lead to the development of industry-leading solutions.
“Miami Cardiac & Vascular Institute is a pioneer and globally one of our most valuable partners,” Mr. van Houten said. “The Institute has helped Philips deliver several of the industry’s firsts in cardiovascular care, and we’re very proud of having been part of its recent expansion.”